Thrombosis
Thrombosis refers to the formation of abnormal blood clots in the circulating blood or blood deposits on the inner wall of the heart or blood vessel walls due to certain inducements during the survival of the human body or animal.
-
Site of disease:
Blood vessels -
Infectious :
Not contagious -
Frequent population:
Middle-aged and elderly people -
Related symptoms:
Difficulty breathing atherosclerosis varicose veins traumatic thrombosis of the internal carotid artery chest pain -
Concurrent disease:
Related Drugs
Flunarizine Hydrochloride Capsules
Indication: (1) Insufficient cerebral blood supply, vertebral artery ischemia, cerebral thrombosis, etc. (2) Tinnitus, dizziness. (3) Prevention of migraine. (4) Auxiliary treatment of epilepsy.
Manufacturer:
Tianjin Pharmaceutical Heping (Tianjin) Pharmaceutical Co., Ltd.
Yanyou Tea
Manufacturer:
Beijing Jiufa Pharmaceutical Co., Ltd.
Flunarizine Hydrochloride Tablets
Indication: (1) Insufficient blood supply to the brain, vertebral artery ischemia, cerebral thrombosis, etc. (2) Tinnitus, dizziness. (3) Prevention of migraine. (4) Auxiliary treatment of epilepsy.
Manufacturer:
Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd.
Flunarizine Hydrochloride Tablets
Indication: 1. Insufficient blood supply to the brain, vertebral artery ischemia, cerebral thrombosis, etc. 2. Tinnitus, dizziness. 3. Prevention of migraine. 4. Auxiliary treatment of epilepsy.
Manufacturer:
Harbin Pharmaceutical Group Pharmaceutical Factory No.6
Flunarizine Hydrochloride Tablets
Indication: 1. Insufficient blood supply to the brain, vertebral artery ischemia, cerebral thrombosis, etc. 2. Tinnitus, dizziness. 3. Prevention of migraine. 4. Auxiliary treatment of epilepsy.
Manufacturer:
Guangdong Lingnan Pharmaceutical Co., Ltd.
Flunarizine Hydrochloride Tablets
Indication: (1) Insufficient blood supply to the brain, vertebral artery ischemia, cerebral thrombosis, etc. (2) Tinnitus, dizziness. (3) Prevention of migraine. (4) Auxiliary treatment of epilepsy.
Manufacturer:
Renhetang Pharmaceutical Co., Ltd.
Urokinase for injection
Indication: This product is mainly used for thrombolytic therapy of thromboembolic diseases, including acute extensive pulmonary embolism, coronary artery embolism and myocardial infarction within 6-12 hours of chest pain, acute cerebral vascular embolism with symptoms shorter than 3-6 hours, retinal artery embolism and other patients with severe iliac vein thrombosis with peripheral arterial embolism symptoms. It is also used to prevent thrombosis after artificial heart valve surgery, maintain patency of vascular cannulation and chest and pericardial drainage tubes, etc. The efficacy of thrombolysis requires subsequent heparin anticoagulation to maintain.
Manufacturer:
Tianjin Biochemical Pharmaceutical Co., Ltd.
Urokinase
Indication: This product is mainly used for thrombolytic therapy of thromboembolic diseases. Including acute extensive pulmonary embolism, coronary artery embolism and myocardial infarction within 6-12 hours of chest pain, acute cerebral vascular embolism with symptoms shorter than 3-6 hours, retinal artery embolism and other patients with severe iliac-femoral vein thrombosis with peripheral arterial embolism symptoms. It is also used to prevent thrombosis after artificial heart valve surgery, maintain patency of vascular cannulation and chest and pericardial drainage tubes, etc. The efficacy of thrombolysis requires subsequent heparin anticoagulation to maintain.
Manufacturer:
Nanjing Nanda Pharmaceutical Co., Ltd.
Urokinase
Indication: This product is mainly used for thrombolytic therapy of thromboembolic diseases. Including acute extensive pulmonary embolism, coronary artery embolism and myocardial infarction within 6-12 hours of chest pain, acute cerebral vascular embolism with symptoms shorter than 3-6 hours, retinal artery embolism and other patients with severe iliac-femoral vein thrombosis with peripheral arterial embolism symptoms. It is also used to prevent thrombosis after artificial heart valve surgery, maintain patency of vascular cannulation and chest and pericardial drainage tubes, etc. The efficacy of thrombolysis requires subsequent heparin anticoagulation to maintain.
Manufacturer:
Nanjing Nanda Pharmaceutical Co., Ltd.
Urokinase
Indication: This product is mainly used for thrombolytic therapy of thromboembolic diseases. Including acute extensive pulmonary embolism, coronary artery embolism and myocardial infarction within 6-12 hours of chest pain, acute cerebral vascular embolism with symptoms shorter than 3-6 hours, retinal artery embolism and other patients with severe iliac-femoral vein thrombosis with peripheral arterial embolism symptoms. It is also used to prevent thrombosis after artificial heart valve surgery, maintain patency of vascular cannulation and chest and pericardial drainage tubes, etc. The efficacy of thrombolysis requires subsequent heparin anticoagulation to maintain.
Manufacturer:
Wuhan Humanwell Pharmaceutical Co., Ltd.